NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Gijs Van De Wetering
Pharmerit International - Rotterdam / Netherlands
Others
AD Scientific Index ID: 5483265
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Gijs Van De Wetering's MOST POPULAR ARTICLES
1-)
A systematic and critical review of the evolving methods and applications of value of information in academia and practiceL Steuten, G van de Wetering, K Groothuis-Oudshoorn, V RetèlPharmacoeconomics 31, 25-48, 2013842013
2-)
The CareWell-primary care program: design of a cluster controlled trial and process evaluation of a complex intervention targeting community-dwelling frail elderlyFGH Ruikes, ARM Meys, G van de Wetering, RP Akkermans, ...BMC Family Practice 13, 1-9, 2012302012
3-)
A model to correct for short‐run inefficiencies in economic evaluations in healthcareG Van de Wetering, WH Woertman, EMM AdangHealth economics 21 (3), 270-281, 2012262012
4-)
Time to incorporate time in cost-effectiveness analysisG van de Wetering, WH Woertman, EM AdangThe European Journal of Health Economics 13, 223-226, 2012242012
5-)
Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United StatesA Chatterjee, S Shapouri, BS Manzoor, A Ravelo, K Sail, V Qendri, ...Journal of Managed Care & Specialty Pharmacy 27 (11), 1532-1544, 2021182021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept